Merck KGaA (ADR)

Factors to consider:

• Company pays dividends (annually): last record date 2026-04-28, amount 0.51$ (Y1.67%)
• Price in estimated range
• Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [22.48$, 33.23$]
• 2026-12-31 to 2027-12-31 estimated range: [23.15$, 34.16$]

Financial Metrics affecting the MKKGY estimates:

• Positive: with PPE of 12.6 at the end of fiscal year the price was neutral
• Positive: Operating profit margin, % of 19.26 > 18.39
• Positive: 6.59 < Operating cash flow per share per price, % of 7.20
• Negative: negative Industry operating cash flow (median)
• Negative: negative Industry operating income (median)
• Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 4.60
• Positive: Inventory ratio change, % of 0.16 <= 0.78
• Negative: Industry inventory ratio change (median), % of 0.87 > 0.28
• Positive: 42.59 < Shareholder equity ratio, % of 54.88 <= 64.29
• Negative: 0.01 < Interest expense per share per price, % of 0.48